Science News

COVID-19 Professional Resources
The AHA is working to ensure optimal care for patients with cardiovascular disease who contract coronavirus (COVID-19). Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with COVID-19. Here are some helpful resources for health systems, clinics, care providers, patients and the public.
Circulation: Cardiovascular Quality and Outcomes Just Published on COVID-19
03/19/2020 | Circulation: Cardiovascular Quality and Outcomes Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment?Elevation Myocardial Infarction Care in Hong Kong, China
CIRCULATION Editor's Picks | Feb/March 2020
03/19/2020 | CIRCULATON Editor's Picks for January 2020
HFSA/ACC/AHA statement addresses concerns re: using RAAS antagonists in COVID-19
03/16/2020 | Patients with underlying cardiovascular diseases appear to have an increased risk for adverse outcomes with coronavirus disease 2019 (COVID-19).
JAHA Conference Reads| EPI Lifestyle 2020
03/02/2020 | JAHA Conference Reads for EPI Lifestyle 2020
CIRCULATION: CARDIOVASCULAR INTERVENTIONS | Twitter Journal Club | February 2
01/30/2020 | Circulation: Cardiovascular Interventions, Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders
Heart Disease and Stroke Statistics - 2020 Update
01/29/2020 | The age-adjusted death rate attributable to cardiovascular disease (CVD), based on 2017 data, is 219.4 per 100,000.
Cardiovascular Health and Disease Surveillance for 2030 and Beyond
01/29/2020 | Surveillance is a tool that captures current heart disease and stroke data, accommodating analysis and ultimately enhancements to the public health system?s abilities to improve outcomes.
The AHA 2030 Impact Goal
01/29/2020 | Since the late 1990s, the AHA has committed to a singular impact goal to advance the AHA?s mission for the decade ahead.